Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 6/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.46 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | HTR1A | P08908 | 4/20 | 0.41 |
| ▸ | CCR1 | P32246 | 2/20 | 0.40 |
| ▸ | TACR1 | P25103 | 3/20 | 0.39 |
| ▸ | TACR2 | P21452 | 2/20 | 0.38 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | LTA4H | P09960 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7953361 | 0.91 | OPRL1 (0.39) | OPRL1OPRM1OPRD1HTR1ACCR1 | |
| SCHEMBL7965755 | 0.91 | TACR2 (0.40) | OPRL1OPRM1OPRD1HTR1ACCR1 | |
| SCHEMBL7969555 | 0.90 | OPRL1 (0.45) | OPRL1OPRM1OPRD1HTR1ACCR1 | |
| SCHEMBL7953456 | 0.88 | OPRL1 (0.39) | OPRL1OPRM1OPRD1HTR1ACCR1 | |
| SCHEMBL7969312 | 0.88 | LTA4H (0.45) | OPRL1OPRM1OPRD1HTR1ACCR1 | |
| SCHEMBL7953348 | 0.88 | MEN1 (0.47) | OPRL1OPRM1OPRD1HTR1ACCR1 | |
| SCHEMBL7966953 | 0.88 | OPRL1 (0.39) | OPRL1OPRM1OPRD1HTR1ACCR1 | |
| SCHEMBL7965175 | 0.88 | OPRL1 (0.47) | OPRL1OPRM1HTR1ACCR1DRD2 | |
| SCHEMBL7200725 | 0.88 | OPRL1 (0.41) | OPRL1OPRM1OPRD1HTR1ACCR1 | |
| SCHEMBL7966386 | 0.86 | LTA4H (0.38) | OPRL1OPRM1OPRD1HTR1ATACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6242450-B1 | SUBSTITUTED PIPERIDINES | ELI LILLY AND COMPANY | 2001-06-05 | — | — | US | disclosed |
| WO-2000006082-A2 | TREATMENT OF ANXIETY DISORDERS | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| WO-2000006166-A1 | 5-HT1F ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2000-02-10 | — | — | WO | disclosed |
| EP-0976746-A1 | 5-HT1F antagonists | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |
| EP-0976747-A2 | Use of 5HT-1F receptor antagonists for treating anxiety disorders | ELI LILLY AND COMPANY (US) | 2000-02-02 | — | — | EP | disclosed |